Asthma Clinical Trial
Official title:
Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children
The investigators have developed a tool to facilitate asthma self-management in children, the
electronic-AsthmaTracker (e-AT). The e-AT changes ambulatory asthma care delivery to a new
model that is continuous and proactive, focusing on prevention and control, rather than
reactive and focusing on management of asthma attacks. The e-AT 1) engages parents in weekly
monitoring of their child's chronic asthma symptoms, 2) guides parents to recognize warning
signs of asthma attacks in order to prompt appropriate interventions and timely visits to
Primary Care Providers, and 3) provides Primary Care Providers with real-time, objective
patient data to assess the effectiveness of asthma therapy and prompt adjustments. In a
preliminary study of the paper-based version of the AT, frequent users had significantly
fewer emergency department (ED) and hospital visits. Parent comments during the e-AT pilot
testing revealed that the tool was useful in helping them manage their child's asthma and
were interested in assessing the tool's effectiveness and in identifying and addressing
barriers to their sustained use of the e-AT.
Improving asthma control in children will be facilitated by broad e-AT dissemination, and by
identifying and addressing critical factors that contribute to parent sustained participation
in self-management. The investigators propose to assess the effectiveness of the new
ambulatory care model supported by the e-AT and conduct an e-AT process evaluation, assessing
barriers and facilitators of sustained parent use. The investigators will engage parents
throughout this study to identify and address themes that matter to them. The target
population is children with persistent asthma, ages 2-17 years. The investigators have
engaged 10 parents since conception of this project, from the planning to design and
validation of the paper-AT, and the design and pilot testing of the e-AT. Input from parents
was received through 3 iterative focus groups (one for the paper-AT and 2 for the e-AT) and
facilitated discussions to inform the development of this proposal including research
objectives and outcome measures. In addition, the investigators have recruited other key
stakeholders for whom the results of the research will be relevant.
Through the following specific aims, the investigators will:
Aim 1: Assess the effectiveness of the new ambulatory care model, by comparing outcomes at
the 1.a. child (child's quality of life (QOL), asthma control, missed school days),
1.b.parent (satisfaction, parent missed work days) and 1.c. clinic (ED/hospital visits)
levels, between clinics randomly assigned to either the standard e-AT intervention vs.
intensive e-AT intervention. 1.d. Use non randomized comparisons to determine the
effectiveness of the e-AT relative to a control group (usual care) in which the e-AT was not
used
Aim 2: Assess the association of QOL, asthma control, and ED/hospital admissions with the
prior frequency of e-AT use and assess if the association differs between parent subgroups
(high vs. low literacy, Medicaid vs. private insurance, and frequent vs. less frequent e-AT
users).
Aim 3: Determine the association of demographic, socio-economic, behavioral, and technology
factors with sustained parent participation in asthma self-management.
The outcome measures are:
Primary Outcome:
1. Child quality of life (QOL)
Secondary Outcomes:
2. Child asthma control
3. Child interrupted/missed school days
4. Child use of oral steroids (surrogate measure of an asthma exacerbation)
5. Parent satisfaction with care
6. Parent interruption/missed work days
7. Clinics: ED/Hospital admissions
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|